文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症肺炎患者下呼吸道疱疹病毒图谱:多中心回顾性研究及前瞻性验证

The Landscape of lower respiratory tract herpesviruses in severe pneumonia patients: a multicenter, retrospective study with prospective validation.
PubMed 文献 · Crit Care · 2025-06-20
一句话结论重症肺炎患者下呼吸道疱疹病毒常见,单纯检出任一疱疹病毒与28天死亡率无独立关联,但HSV-1与CMV共检出与28天死亡率升高独立相关(adj-HR=1.439)。

该多中心回顾性研究纳入17个医疗中心ICU中2019年1月至2023年6月接受支气管肺泡灌洗液宏基因组检测的重症肺炎患者1737例,28天死亡率为41.3%(718/1737)。828例检出疱疹病毒,检出率分别为HSV-1(26.8%)、CMV(17.8%)、EBV(16.6%)、HHV-7(5.3%)、HHV-6B(2.2%)、VZV(0.5%)。经倾向性评分匹配和多因素Cox回归,单一疱疹病毒均未与死亡率升高独立相关;但HSV-1与CMV共检出与28天死亡率升高显著相关(vs 两者均阴性:adj-HR=1.439,95%CI 1.093-1.894,P=0.009),并在前瞻性多中心队列中验证(adj-HR=1.656,95%CI 1.061-2.585,P=0.026)。

要点

  • 重症肺炎患者BALF宏基因组检测中疱疹病毒检出常见,总体28天死亡率为41.3%(718/1737)。
  • 单一检出HSV-1、CMV、EBV、HHV-6B或HHV-7均未与28天死亡率升高独立相关。
  • HSV-1与CMV共检出与28天死亡率升高独立相关(vs 两者均阴性:adj-HR=1.439,95%CI 1.093-1.894,P=0.009)。
  • 上述共检出与死亡率的关联在前瞻性多中心队列中得到验证(adj-HR=1.656,95%CI 1.061-2.585,P=0.026)。
  • 不同疱疹病毒组临床特征存在差异。

适用人群与场景

  • 2019年1月至2023年6月在17个医疗中心ICU住院、接受支气管肺泡灌洗液宏基因组检测的重症肺炎患者。

研究设计与关键结果

  • 研究类型:多中心回顾性研究,并以前瞻性多中心队列验证主要发现;纳入17个医疗中心ICU的1737例重症肺炎患者。
  • 总体28天死亡率为41.3%(718/1737);828例检出疱疹病毒。
  • 检出率:HSV-1 26.8%、CMV 17.8%、EBV 16.6%、HHV-7 5.3%、HHV-6B 2.2%、VZV 0.5%。
  • 与疱疹病毒阴性组相比,单一HSV-1、EBV、CMV、HHV-6B或HHV-7检出均未与28天死亡率升高独立相关。
  • HSV-1与CMV共检出与28天死亡率升高显著相关(vs 两者均阴性:adj-HR=1.439,95%CI 1.093-1.894,P=0.009)。
  • 上述关联在前瞻性队列中验证(adj-HR=1.656,95%CI 1.061-2.585,P=0.026)。

证据类型、等级与局限

  • 证据类型:多中心回顾性研究加前瞻性队列验证。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对重症肺炎患者,BALF宏基因组检测出单一疱疹病毒(HSV-1、EBV、CMV、HHV-6B或HHV-7)本身不应被解读为与28天死亡率升高独立相关。
  • 当BALF宏基因组检测同时检出HSV-1与CMV时,提示28天死亡率升高风险(adj-HR=1.439),可据此加强病情评估与监测。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: Herpesviruses are widely distributed in the lower respiratory tract, yet no study has comprehensively characterized their clinical features and prognostic impact in severe pneumonia.

METHOD: In this multicenter, retrospective study, we included severe pneumonia patients who underwent bronchoalveolar lavage fluid (BALF) metagenomic testing in intensive care units across 17 medical centers from January 2019 to June 2023. Based on metagenomic results, patients were categorized into herpesvirus-negative, HSV-1, EBV, CMV, HHV-6B, and HHV-7 groups. Propensity score matching and multivariable Cox regression were used to compare mortality between herpesvirus-positive and -negative patients. Interaction analyses were conducted to assess the impact of co-detection of different herpesviruses. Besides, main findings were validated using data from a prospective multicenter cohort.

RESULTS: Among 1,737 enrolled patients, the 28-day mortality rate was 41.3% (718/1,737). Herpesviruses were detected in 828 patients. Detection frequencies were: HSV-1 (26.8%), CMV (17.8%), EBV (16.6%), HHV-7 (5.3%), HHV-6B (2.2%), and VZV (0.5%). Clinical characteristics varied across herpesvirus groups. No single herpesvirus was independently associated with increased mortality compared to the negative group. However, co-detection of HSV-1 and CMV was significantly associated with higher 28-day mortality (vs. both negative: adj-HR = 1.439, 95% CI: 1.093-1.894, P = 0.009). This finding was validated in a prospective cohort (adj-HR = 1.656, 95% CI: 1.061-2.585, P = 0.026).

CONCLUSIONS: Herpesviruses are frequently detected in the lower respiratory tract of patients with severe pneumonia, with distinct clinical features across virus types. Co-detection of HSV-1 and CMV was associated with increased 28-day mortality.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Liu F, Zhuang Y, Huang X, et al. The Landscape of lower respiratory tract herpesviruses in severe pneumonia patients: a multicenter, retrospective study with prospective validation. Crit Care. 2025. PMID: 40542368. doi:10.1186/s13054-025-05496-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。